Interventions
cholangitis
CHOLANGITIS
Patients with mild cholangitis received either CSTS at 50 mg/kg, Q12h or MEPM at 20 mg/kg, Q8h. Patients with moderate cholangitis received intravenous MEPM at 20 mg/kg, Q8h. Patients with severe cholangitis received either intravenous MEPM at 20 mg/kg, Q8h, or MEPM+IVIG (IVIG, 400 mg/kg, Q24h, for 3 days).Other post-Kasai treatments were the same in all groups, including intravenous ornidazole at 20 mg. mg/kg, Q24h, steroids (oral prednisone at 5 mg mg/kg, Q24h, for 5 days), ursodeoxycholic acid (oral UDCA at 10 mg mg/kg, twice daily), liver-protective drugs, and vitamin A, vitamin D, and vitamin K supplements